FATE - Fate Therapeutics GAAP EPS of -$0.46 beats by $0.12 revenue of $1.94M beats by $1.04M November, 08 2023 04:02 PM Fate Therapeutics Inc. 2023-11-08 16:02:03 ET Fate Therapeutics press release ( NASDAQ: FATE ): Q3 GAAP EPS of -$0.46 beats by $0.12 . Revenue of $1.94M (-87.0% Y/Y) beats by $1.04M . For further details see: Fate Therapeutics GAAP EPS of -$0.46 beats by $0.12, revenue of $1.94M beats by $1.04M